Researchers study strategies for using nanotechnology to boost cancer therapeutics

April 11, 2019

University of North Carolina Lineberger Comprehensive Cancer Center researchers presented innovative new strategies for using tiny particles – particles the size of a DNA molecule or the width of a human hair – to boost cancer treatment as part of the Carolina Center of Cancer Nanotechnology Excellence/National Cancer Institute site visit on Tuesday. The researchers, … Continued

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells

December 3, 2015

The new cancer drug delivery system developed by the UNC School of Medicine and North Carolina State University improves efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.

Wang published in ACS Nano

August 18, 2015

UNC Lineberger member Andrew Wang, MD, was senior author of a preclinical study published in the journal ACS Nano. Wang and collaborators found that they could improve cancer chemotherapy and chemoradiotherapy treatments by delivering a combination of cancer-fighting drugs using nanoparticles.

Grant will support study of nanomaterials to improve cancer drug delivery

August 14, 2015

A $2.4 million-grant from the National Institutes of Health will fund a collaborative research effort between UNC Lineberger Comprehensive Cancer Center and University of Nebraska Medical Center scientists. The researchers plan to study whether the use of a drug-carrying nanoparticle material they’ve designed can better penetrate tumors.

DeSimone talks about research, developing new medicines

March 12, 2012

Joseph DeSimone, PhD, talks about the Bill & Melinda Gates Foundation’s investment in Liquidia Technologies and the company’s current and planned research in the article “Particle Technology Delivers Medicines and Vaccines” published March 9, 2012 in U.S. News & World Report. Read more about the Bill & Melinda Gates Foundation’s investment.

UNC study shows potential for nanotechnology-based therapy for ovarian cancer

August 30, 2011

Chapel Hill – A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.